Today announced that the U.

Alkermes receives tentative schedule notification for FDA advisory committee meeting on VIVITROL sNDA Alkermes, Inc . today announced that the U.S. Notification of the potential advisory committee interacting with follows a designation in-may 2010 by the FDA of priority review of the VIVITROL sNDA, a designation that accelerates the FDA’s focus on review timeline from ten to six months for drugs offering major advancements in treatment or give a treatment where no adequate therapy exists. With priority review, the Prescription Medication User Fee Take action day for the FDA’s decision regarding acceptance of the VIVITROL sNDA for opioid dependence is definitely October 12, 2010.

With treatment, three out of four strokes linked to AF could be prevented, conserving lives and reducing the city burden of stroke possibly. The AliveCor Heart Monitor is intended to record, store and transfer single-channel ECG rhythms. The AliveCor Cardiovascular Monitor displays ECG rhythms and detects the current presence of atrial fibrillation also. The AliveCor Heart Monitor is intended for use by health care professionals, patients with known or suspected heart health insurance and conditions conscious individuals. The AliveCor Heart Monitor is compatible with all iOS & most Android OS mobile devices. With secure storage space in the cloud, users have the ability to gain access to their data confidentially anytime, anywhere.. AliveCor receives CE Tag clearance for algorithm to detect atrial fibrillation AliveCor, Inc.